Method of screening for potential anti-bacterial agents

Details Method of screening for potential anti-bacterial agents Method of screening for potential anti-bacterial agents

2008-04-08

2008-04-08

Gitomer, Ralph (Department: 1657)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving transferase

C435S004000, C435S032000

Reexamination Certificate

active

07354731

ABSTRACT:
The invention provides a method of screening for potential anti-bacterial agents being antagonists of one or both of the transglycosylase and the transpeptidase enzymes involved in peptidoglycan biosynthesis in bacteria. The method is suitable for high throughput screening of compounds.

REFERENCES:
patent: 6537770 (2003-03-01), Das et al.
patent: 6913895 (2005-07-01), Goldman et al.
patent: 6955886 (2005-10-01), Desousa et al.
patent: 2003/0129683 (2003-07-01), Kahne
patent: 2006/0228766 (2006-10-01), Desousa et al.
patent: 0 154 734 (1990-08-01), None
patent: 0 378 059 (1993-09-01), None
patent: WO-96/16082 (1996-05-01), None
patent: WO 96/16082 (1996-05-01), None
patent: WO-99/38958 (1999-08-01), None
patent: WO-99/60155 (1999-11-01), None
patent: WO 99/60155 (1999-11-01), None
patent: WO-00/10587 (2000-03-01), None
patent: WO-00/52035 (2000-09-01), None
patent: WO-01/12142 (2001-02-01), None
patent: WO-01/94622 (2001-12-01), None
patent: WO 01/94622 (2001-12-01), None
patent: WO-01/94623 (2001-12-01), None
patent: WO 01/94623 (2001-12-01), None
Chandrakala B. et al. Novel Scintillation Proximity Assay for Measuring Membrane Associated Steps of Peptidoglycan Biosynthesis inE. coli. Antimicrobial Agents and Chemotherapy. Mar. 2001 45(3)768-775.
Chandrakala B. et al. High Throughput Screen for Inhibitors of Transglycosylase and/or Transpeptidase Activities ofE. coliPencillin Binding Protein 1b. Antimicrobial Agents and Chemotherapy. Jan. 2004 48(1)30-40.
Chandrakala B. et al. Assay for Inhibitors of the Transglycosylase and Transpeptidase Activities of the Penicillin Binding Protein. Antimicrobial Agents and Chemotherapy, Abstracts of the Interscience Conference Sep. 27-30, 2002. 2002, vol. 42, p. 191 F-718 abstract.
Barbosa, M.D.F., et al., “Development of a Pathway Assay to Screen for Bacterial Cell Wall Biosynthesis Inhibitors,” 41:248 (2001) XP009010101.
Boyle, D.S., et al., “mraY is an Essential Gene for Cell Growth inEscherichia coli,” Journal of Bacteriology, 180(23):6429-6432 (1998).
Branstrom, A.A., et al., “In situ assay for identifying inhibitors of bacterial transglycosylase,” FEMS Microbiology Letters, 191: 187-190 (2000).
Chandrakala, B., et al., “Novel Scintillation Proximity Assay for Measuring Membrane-Associated Steps of Peptidoglycan Biosynthesis inEscherchia coli,” Antimicrobial Agents and Chemotherapy, 45(3):768-775 (2001).
dem Blaauwen, T., et al., “Interaction of Monoclonal Antibodies with the Enzymatic Domains of Penicillin-Binding Protein 1b ofEscherichia coli,” Journal of Bacteriology, 172(1):63-70 (1990).
Denome, S.A., et al., “Escherichia coliMutants Lacking All Possible Combinations of Eight Penicillin Binding Proteins: Viability, Characteristics, and Implications for Peptidoglycan Synthesis,” Journal of Bacteriology, 181(13):3981-3993 (1999).
Ge, M., et al., “Vancomycin Derivatives That Inhibit Peptidoglycan Biosynthesis Without Binding D-Ala-D-Ala,” Science, 284:507-511 (1999).
Goldman, R.C., et al., “Chlorobiphenyl-deseucyl-vancomycin inhibits the transglycosylation process required for peptidoglycan synthesis in bacteria in the absence of dipeptide binding,” FEMS Microbiology Letters, 183:209-214 (2000).
Lefevre, F., “Topographical and Functional Investigation ofEscherichia coliPenicillin-Binding Protein 1b by Alanine Stretch Scanning Mutagenesis,” Journal of Bacteriology, 179(15):4761-4767 (1997).
Lo, M.C., et al., “A New Mechanism of Action Proposed for Ramoplanin,” J. Am. Chem. Soc., 122:3540-3541 (2000).
Mengin-Lecreuix, D., et al., “The murG Gene ofEscherichia coliCodes for the UDP-N-Acetylglucosamine:N-Acetylmuramyl-(Pentapeptide) Pyrophosphoryl-Undecaprenol N-Acetylglucosamine Transferase Involved in the Membrane Steps of Peptidoglycan Synthesis,” 173(15):4625-4636 (1991).
Pinho, M.G., et al., “An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci,” PNAS, 98(19): 10886-10891 (2001).
Tamura, T., et al., “On the process of cellular division inEscherichia coli: Isolation and characterization of penicillin-binding proteins 1a, 1b, and 3,” Proc. Natl. Acad. Sci. USA, 77(8):4499-4503 (1980).
van Heijenoort, Y., et al., “Membrane Intermediates in the Peptidoglycan Metabolism ofEscherichia coli: Possible Roles of PBP 1b of PBP 3,” Journal of Bacteriology, 174(11):3549-3557 (1992).
Yousif, S.Y., “Lysis ofEscherichia coliby β-Lactam Antibiotics: Deletion Analysis of the Role of Penicillin-binding Proteins 1A and 1B,” Journal of General Microbiology, 131:2839-2845 (1985).

Affiliated with

Also associated with

Rating

Method of screening for potential anti-bacterial agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of screening for potential anti-bacterial agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of screening for potential anti-bacterial agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2753666